Cargando…

Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration

BACKGROUND AND OBJECTIVE: PL8177 is a selective melanocortin 1 receptor agonist in development for the treatment of various immunologic and inflammatory conditions. Here we describe the pharmacokinetics of PL8177 after subcutaneous (sc) delivery in animals and humans. METHODS: Mice, rats, and dogs w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodd, John, Jordan, Robert, Makhlina, Marie, Pesco Koplowitz, Luana, Koplowitz, Barry, Barnett, Keith, Yang, Wei H., Spana, Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602434/ https://www.ncbi.nlm.nih.gov/pubmed/34693509 http://dx.doi.org/10.1007/s40268-021-00367-y

Ejemplares similares

A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans
por: Dodd, John, et al.
Publicado: (2023)

Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
por: Garrido-Mesa, Jose, et al.
Publicado: (2022)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases
por: Spana, Carl, et al.
Publicado: (2019)

Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System
por: Greuber, Emileigh, et al.
Publicado: (2021)

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease
por: Evans, David, et al.
Publicado: (2023)

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers
por: Hogan, R. Edward, et al.
Publicado: (2020)

Assessing cardiac safety in oncology drug development
por: Seltzer, Jonathan H, et al.
Publicado: (2019)

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review
por: Rabe, Heike, et al.
Publicado: (2021)

The Importance of Melanocortin Receptors and Their Agonists in Pulmonary Disease
por: Moscowitz, Anna Elizabeth, et al.
Publicado: (2019)

Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide
por: White, William B., et al.
Publicado: (2017)

Effects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies
por: Lindskog Jonsson, Annika, et al.
Publicado: (2014)

Interactions of the Melanocortin-4 Receptor with the Peptide Agonist NDP-MSH
por: Chapman, Kathryn L., et al.
Publicado: (2010)

Ustekinumab pharmacokinetics after subcutaneous administration in swine model
por: Grabowski, Tomasz, et al.
Publicado: (2021)

Melanocortin agonists stimulate lipolysis in human adipose tissue explants but not in adipocytes
por: Møller, Cathrine Laustrup, et al.
Publicado: (2015)

Melanocortins, Melanocortin Receptors and Multiple Sclerosis
por: Lisak, Robert P., et al.
Publicado: (2017)

Pharmacokinetics of Tildipirosin in Ewes after Intravenous, Intramuscular and Subcutaneous Administration
por: Galecio, Juan Sebastián, et al.
Publicado: (2020)

Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration
por: Fadel, Charbel, et al.
Publicado: (2022)

Gene Expression Regulation by Agonist-Independent Constitutive Signaling of Melanocortin-1 Receptor
por: Seong, Ikjoo, et al.
Publicado: (2014)

Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits
por: Drobnjak, Tijana, et al.
Publicado: (2018)

Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration
por: Walters, Rodney R., et al.
Publicado: (2021)

Pharmacokinetics and toxicity of subcutaneous administration of carboplatin in poloxamer 407 in a rodent model pilot study
por: Risselada, Marije, et al.
Publicado: (2017)

Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2021)

Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
por: Haws, Robert, et al.
Publicado: (2020)

Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration
por: Ashraf, Muhammad W., et al.
Publicado: (2020)

Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model
por: Teigen, Ingrid Anna, et al.
Publicado: (2022)

Pharmacokinetics of esomeprazole in goats (Capra aegagrus hircus) after intravenous and subcutaneous administration
por: Fladung, Rachel, et al.
Publicado: (2022)

Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment
por: Ayers, Kristin L, et al.
Publicado: (2018)

Melanogenic effect of dersimelagon (MT‐7117), a novel oral melanocortin 1 receptor agonist
por: Suzuki, T., et al.
Publicado: (2021)

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
por: Collet, Tinh-Hai, et al.
Publicado: (2017)

Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
por: Sitovs, Andrejs, et al.
Publicado: (2020)

Melanocortin Regulation of Inflammation
por: Wang, Wei, et al.
Publicado: (2019)

The Multifaceted Melanocortin Receptors
por: Laiho, Linda, et al.
Publicado: (2022)

Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies
por: Rinne, Petteri, et al.
Publicado: (2023)

Pharmacokinetics of tramadol after subcutaneous administration in a critically ill population and in a healthy cohort
por: Dooney, Neil M, et al.
Publicado: (2014)

Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021)

Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system
por: Kaineder, K, et al.
Publicado: (2017)

Subcutaneous REGEN-COV antibody administration in a community pharmacy
por: Dougherty, Tyler S., et al.
Publicado: (2023)

Observations on the Evolution of the Melanocortin Receptor Gene Family: Distinctive Features of the Melanocortin-2 Receptor
por: Dores, Robert M.
Publicado: (2013)

Melanocortin regulation of histaminergic neurons via perifornical lateral hypothalamic melanocortin 4 receptors
por: Michael, Natalie J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c7t20q0n34ale6re2sucpl51f2